Private Advisor Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Private Advisor Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-243	Closed	-$15K	–	2937
2020 Q2	$15K	Buy	+243	New	+$14.7K	﹤0.01%	2730

Other funds holding PPH

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Private Advisor Group's PPH Position: Q3 2020 in Review

Private Advisor Group sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2020, closing a stake of 243 shares — an estimated $15K sold.

Private Advisor Group first reported a position in PPH in Q2 2020 and held it in 1 quarter. The position peaked at $15K in Q2 2020. 47 funds tracked by Wall St. Rank hold PPH as of Q3 2020.

Private Advisor Group reported no remaining VanEck Pharmaceutical ETF position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 243 VanEck Pharmaceutical ETF shares in Q3 2020, an estimated $15K.
Private Advisor Group first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and held it in 1 quarter.
Private Advisor Group's VanEck Pharmaceutical ETF position peaked at $15K in Q2 2020.
47 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.